Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   familial lipoprotein lipase deficiency
  

Disease ID 309
Disease familial lipoprotein lipase deficiency
Definition
rare familial condition characterized by massive chylomicronemia and decreased levels of other lipoproteins; due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyzes an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood.
Synonym
buerger-gruetz syndrome
burger grutz syndrome
burger-grutz syndrome
burger-grutz syndromes
chylomicronemia, familial
chylomicronemias, familial
deficiencies, familial lpl
deficiencies, lipase d
deficiencies, lipd
deficiencies, lipoprotein lipase
deficiency, familial lpl
deficiency, lipase d
deficiency, lipd
deficiency, lipoprotein lipase
endogenous hypertriglyceridaemia
endogenous hypertriglyceridemia
essential familial hyperlipemia
essential familial hyperlipemias
familial chylomicronemia
familial chylomicronemias
familial fat-induced hypertriglyceridaemia
familial fat-induced hypertriglyceridemia
familial hyperchylomicronaemia
familial hyperchylomicronemia
familial hyperchylomicronemia (disorder)
familial hyperchylomicronemias
familial hyperlipemia, essential
familial hyperlipemias, essential
familial hyperlipoproteinaemia, type i
familial hyperlipoproteinemia type 1
familial hyperlipoproteinemia type i
familial hyperlipoproteinemia, type i
familial lipoprotein lipase defic
familial lipoprotein lipase deficiency (disorder)
familial lipoprotein lipase deficiency (disorder) [ambiguous]
familial lipoprotein lipase deficiency with type i phenotype
familial lipoprotein lipase deficiency with type i phenotype (disorder)
familial lpl deficiencies
familial lpl deficiency
familial type i hyperlipoproteinaemia
familial type i hyperlipoproteinemia
fredrickson type i hyperlipoproteinaemia
fredrickson type i hyperlipoproteinemia
fredrickson type i hyperlipoproteinemia (disorder)
fredrickson type i lipaemia
fredrickson type i lipemia
fredrickson type i or v hyperlipoproteinemia
hepatosplenomegalic lipoidosis
hypercholesterinaemic xanthomatosis
hypercholesterinemic xanthomatosis
hyperchylomicronaemia
hyperchylomicronemia
hyperchylomicronemia, familial
hyperchylomicronemias, familial
hyperlipemia, essential familial
hyperlipemia, idiopathic familial
hyperlipemia, idiopathic, burger-grutz type
hyperlipemia, retention
hyperlipemias, essential familial
hyperlipidemia, group d
hyperlipoproteinaemia, type i
hyperlipoproteinemia type 01
hyperlipoproteinemia type i
hyperlipoproteinemia type i [disease/finding]
hyperlipoproteinemia type ia
hyperlipoproteinemia type ias
hyperlipoproteinemia type is
hyperlipoproteinemia, type i
hyperlipoproteinemia, type ia
hyperlipoproteinemias, type i
hyperlipoproteinemias, type ia
lipase d deficiencies
lipase d deficiency
lipase deficiencies, lipoprotein
lipd deficiencies
lipd deficiency
lipoprotein lipase defic familial
lipoprotein lipase deficiencies
lipoprotein lipase deficiency
lipoprotein lipase deficiency, familial
lpl deficiencies, familial
lpl deficiency
lpl deficiency, familial
mixed hyperglyceridemia
primary hyperchylomicronaemia
primary hyperchylomicronemia
syndrome, burger-grutz
syndromes, burger-grutz
type i hyperlipoproteinemia
type i hyperlipoproteinemias
type ia hyperlipoproteinemia
type ia hyperlipoproteinemias
Orphanet
OMIM
DOID
ICD10
UMLS
C0023817
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:9)
C0030305  |  pancreatitis  |  4
C0878544  |  cardiomyopathy  |  1
C0023817  |  hyperchylomicronaemia  |  1
C0007194  |  hypertrophic cardiomyopathy  |  1
C0001339  |  acute pancreatitis  |  1
C0023817  |  lpl deficiency  |  1
C0149521  |  recurrent pancreatitis  |  1
C0006142  |  breast cancer  |  1
C0023817  |  type i hyperlipoproteinemia  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:2)
4023  |  LPL  |  CLINVAR;CTD_human;GHR;ORPHANET;UNIPROT
344  |  APOC2  |  CTD_human
Inferring Gene(Waiting for update.)
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:14)
336  |  APOA2  |  2.533  |  DISEASES
344  |  APOC2  |  4.36  |  DISEASES
347  |  APOD  |  2.274  |  DISEASES
23607  |  CD2AP  |  1.417  |  DISEASES
28514  |  DLL1  |  1.468  |  DISEASES
2673  |  GFPT1  |  1.785  |  DISEASES
338328  |  GPIHBP1  |  5.277  |  DISEASES
55656  |  INTS8  |  3.687  |  DISEASES
3949  |  LDLR  |  1.119  |  DISEASES
4018  |  LPA  |  1.71  |  DISEASES
5251  |  PHEX  |  1.473  |  DISEASES
5406  |  PNLIP  |  3.493  |  DISEASES
26278  |  SACS  |  2.282  |  DISEASES
7391  |  USF1  |  1.724  |  DISEASES
Locus
Symbol | Locus(Total Locus:1)
LPL  |  8p21.3
Disease ID 309
Disease familial lipoprotein lipase deficiency
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:11)
HP:0001733  |  Pancreatic inflammation  |  4
HP:0002155  |  Increased triglycerides  |  2
HP:0001639  |  Hypertrophic cardiomyopathy  |  1
HP:0001735  |  Acute pancreatitis  |  1
HP:0000660  |  Lipemia retinalis  |  1
HP:0002027  |  Abdominal pain  |  1
HP:0003002  |  Breast carcinoma  |  1
HP:0003077  |  Hyperlipidemia  |  1
HP:0100027  |  Recurring pancreatitis  |  1
HP:0001638  |  Cardiomyopathy  |  1
HP:0012531  |  Pain  |  1
Disease ID 309
Disease familial lipoprotein lipase deficiency
Manually Symptom
UMLS  | Name(Total Manually Symptoms:3)
C1963198  |  pancreatitis
C0149521  |  recurrent pancreatitis
C0011860  |  diabetes
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C0030305  |  pancreatitis  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:42)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs118204056NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954185GA
rs118204057158772024023LPLumls:C0023817UNIPROTHyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.0.5885113282005LPL819954222GA
rs118204057NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954222GA
rs118204058NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819951916CT
rs118204059NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819955876TA
rs118204060NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954279CT
rs118204061NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954240TC
rs118204062NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819955874GA
rs118204063NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819953386GA
rs118204064NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954126AG
rs118204065NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819951783TA
rs118204066NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819960988GA
rs118204067NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954271CG
rs118204068NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819955894GA
rs118204069NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819951856TC
rs118204070NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819951791GA
rs118204071NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819959322GA
rs118204072NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954174CG,T
rs118204073NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819951825AC
rs118204074NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819951819CA
rs118204075NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954243GA
rs118204076NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954199CG,T
rs118204077NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819955873CT
rs118204078NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819960935CG
rs118204079NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819962126GA
rs118204080NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819954333TC
rs118204081NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819956052CA
rs118204082NA4023LPLumls:C0023817CLINVARNA0.588511328NALPL819955863CG,T
rs1219093971982002264788LMF1umls:C0023817BeFreeLPL deficiency in our patient was milder than in the carrier of the Y439X previously described.0.0005428842009LMF116869982GC,A
rs136175192399058542APOL1umls:C0023817BeFreeThe Lys166Glu and Ile244Met polymorphisms in apoL-I gene are associated with TG levels in subjects with endogenous hypertriglyceridemia in Chinese.0.0005428842009APOL12236265520GA
rs14584432921816778338328GPIHBP1umls:C0023817BeFreeGPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.0.0019000932011GPIHBP18143215486GA,C
rs14908992094980994023LPLumls:C0023817UNIPROTA novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis.0.5885113281998LPL819962134GA
rs1800011152567644023LPLumls:C0023817UNIPROTMutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--.0.5885113282004LPL819955927GA,C
rs1801177129660364023LPLumls:C0023817UNIPROTAssociation of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.0.5885113282003LPL819948197GA,C
rs20107948519447388116519APOA5umls:C0023817BeFreeThe Q97X mutation was clearly involved in hyperchylomicronemia with evidence of concomitant altered intravascular lipolysis, and a complete apoAV deficiency in the homozygote.0.0039956832009APOA511116790940GA,T
rs2239785192399058542APOL1umls:C0023817BeFreeThe Lys166Glu and Ile244Met polymorphisms in apoL-I gene are associated with TG levels in subjects with endogenous hypertriglyceridemia in Chinese.0.0005428842009APOL12236265284GA
rs268129660364023LPLumls:C0023817UNIPROTAssociation of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.0.5885113282003LPL819956018AG
rs2893489321210254023LPLumls:C0023817UNIPROTCompound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene.0.5885113281990NANANANANA
rs313550618468520116519APOA5umls:C0023817BeFreeAssociation of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.0.0039956832008APOA511116791691GA,C
rs35414700122040014023LPLumls:C0023817UNIPROTGenotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia.0.5885113282002LPL819955901TG
rs528243561152567644023LPLumls:C0023817UNIPROTMutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--.0.5885113282004LPL819954258TC
rs546542623122040014023LPLumls:C0023817UNIPROTGenotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia.0.5885113282002LPL819959335CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 309
Disease familial lipoprotein lipase deficiency
Case(Waiting for update.)